References
- Al Ghobain M., Algazlan S.S., Oreibi T.M.: Asthma prevalence among adults in Saudi Arabia. Saudi Med J. 39, 179–184 (2018)
- Al-Moamary M.S., Al-Hajjaj M.S., et al.: The Saudi initiative for asthma – 2021 update: Guidelines for the diagnosis and management of asthma in adults and children. Ann Thorac Med. 16, 4–56 (2021)
- Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D.M.E., Fouchier R.A.M.: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 367, 18–1820 (2012)
- Wang Y., Wang Y., Chen Y., Qin Q.: Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 92, 568–576 (2020)
- Huang C., Cao B.: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395, 497–506 (2020)
- Shang J., Wan Y., Luo C., Ye G., Geng Q., Auerbach A., Li F.: Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA, 26, 117, 11727–11734 (2020)
- Jackson C.B., Farzan M., Chen B., Choe H.: Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 23, 3–20 (2022)
- Zhong N.S., Guan Y. et al.: Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February 2003. Lancet, 362, 1353–1358 (2003)
- Bhat E.A., Sajjad N., Ali A., Aldakeel F.M., Mateen A., Alqahtani M.S., Syed, R.: SARS-CoV-2: insight in genome structure, pathogenesis and viral receptor binding analysis-an updated review. International immunopharmacology, 95, p. 107493 (2021)
- Morens D.M., Breman J.G., Calisher C.H., Doherty P..C, Hahn B.H., Keusch G.T., Kramer L.D., LeDuc J.W., Monath T.P., Taubenberger J.K.: The origin of COVID-19 and why it matters. Am J Trop Med Hyg. 103, 955–959 (2020)
- Lee S.C., Son K.J., Han C.H., Jung J.Y., Park S.C.: Impact of comor bid asthma on severity of coronavirus disease (COVID-19). Nat Sci Rep. 10, 21805 (2020)
- Lee S.C., Son K.J, Han C.H., Park S.C., Jung J.Y.: Impact of COPD on COVID-19 prognosis: A nationwide population-based study in South Korea. Nat Sci Rep. 11, 3735 (2021)
- COVID-19 Stats – Realtime coronavirus statistics with charts (epidemic-stats.com) Accessed on: 16th June 2021
- Meo S.A.: COVID-19 pandemic: Saudi Arabia's role at national and international levels. J Diabetes Sci Technol. 14, 758–759 (2020)
- Gao Y., Akdis C.A. et al.: Risk factors for severe and critically ill COVID-19 patients: a review. Allergy, 76, 428–455 (2021)
- Oran D.P., Topol E.J.: The proportion of SARS-CoV-2 infections that are asymptomatic: A systematic review. Ann Intern Med. 174, 655–662 (2021)
- Kimball A., Jernigan J.A. et al.: Public Health-Seattle & King County; CDC COVID-19 investigation team. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a ong-term care skilled nursing facility – King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep. 69, 377 381 (2020)
- Lavezzo E., Crisanti A. et al.: Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo. Nature, 584, 425–429 (2020)
- Rumain B., Schneiderman M., Geliebter A.: Prevalence of COVID-19 in adolescents and youth compared with older adults in states experiencing surges. PLoS ONE, 16, e0242587 (2021)
- Omori R., Matsuyama R., Nakata Y.: The age distribution of mortality from novel coronavirus disease (COVID-19) suggests no large difference of susceptibility by age. Nat Sci Rep. 10, 16642 (2020)
- Wu Z., McGoogan J.M.: Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA, 323, 1239–1242 (2020)
- Aoyagi Y., Inamoto Y., Shibata S., Kagaya H., Otaka Y., Saitoh E.: Clinical manifestation, evaluation, and rehabilitative strategy of dysphagia associated with COVID-19. Am J Phys Med Rehabil. 100, 424–431 (2021)
- Mao L., Hu B. et al.: Neurological manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 77, 683–690 (2021).
- Zimmer M.A., Zink A.K., Weiber C.W., Vogt U., Michelsen A., Priebe H.J., Mols G.: Hypernatremia – A manifestation of COVID-19: A case series. A A Pract. 14(9), e01295 (2020)
- Iranmanesh B., Khalili M., Amiri R., Zartab H., Aflatoonian M.: Oral manifestations of COVID-19 disease: A review article. Dermatol Ther. 34, e14578 (2021)
- Yildirim A.C., Ceviker S.A., Zeren S., Ekici M.F., Yaylak F., Algin M.C., Özlem A.R.I.K.: COVID-19 and related gastrointestinal symptoms: An observational study. Marmara Medical Journal, 35(2), pp. 244–248 (2022)
- Wu P., Duan F., Luo C., Liu Q., Qu X., Liang L., Wu K.: Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 138, 575–578 (2020)
- Tan S.W., Tam Y.C., Oh C.C.: Skin manifestations of COVID-19: A worldwide review. JAAD Int. 2, 119–133 (2021)
- Nepal G., Rehrig J.H., Shrestha G.S., Shing Y.K., Yadav J.K., Ojha R., Pokhrel G., Tu Z.L., Huang D.Y.: Neurological manifestations of COVID-19: a systematic review. Crit Care, 24, 421 (2020)
- Li X., Zhao J. et al.: Risk factors for severity and mortality in adults COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 146, 110–118 (2020)
- Guo L., Shi Z., Zhang Y., Wang C., Moreira N.C.D.V., Zuo H., Hussain A.: Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: A meta-analysis. Diab Res Clin Pract. 166, 108346 (2020)
- Gao F., Zheng K.I., Wang X.B., Sun Q.F., Pan K.H., Wang T.Y., Chen Y.P., Targher G., Byrne C.D., George J., Zheng M.H.: Obesity is a risk factor for greater COVID-19 severity. Diabetes Care, 43, e72–e74 (2020)
- Zhu Z., Hasegawa K., Ma B., Fujiogi M., Camargo Jr C.A., Liang L.: Association of asthma and its genetic predisposition with the risk of severe COVID-19. J Allergy Clin Immunol. 146(2), 327–329 (2020)
- Attaway A.A., Zein J., Hatipoglu U.S.: SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: An analysis of Cleveland clinic's COVID-19 registry. EClinicalMedicine, 26, 100515 (2020)
- Hoffmann M., Pohlmann S. et al.: SARS-CoV-2 entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181, 271–280 (2020)
- Brosnahan S.B., Jonkman A.H., Kugler M.C., Munger J.S., Kaufman D.A.: COVID-19 and respiratory system disorders. Current knowledge, future clinical and translational research questions. Arterioscler Thromb Vasc Biol. 40, 2586–2597 (2020)
- Gattinoni L., Chiumello D., Caironi P., Busana M., Romitti F., Brazzi L., Camporota L.: COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 46, 1099–1102 (2020)
- Bai H.X., Liao W.H. et al.: Artificial intelligence augmentation of radiologist performance in distinguishing COVID-19 from pneumonia of other origin at chest CT. Radiology, 296, E156 E165 (2020)
- Tang N.L., Chan P.K., Wong C.K., To K.F., Wu A.K., Sung Y.M., Hui D.S., Sung J.J., Lam C.W.: Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome. Clin Chem. 51, 2333–2340 (2005)
- Wang J., Nikrad M.P., Phang T., Gao B., Alford T., Ito Y., Edeen K., Travanty E.A., Kosmider B., Hartshorn K., Mason R.J.: Innate immune response to influenza A virus in differentiated human alveolar. American journal of respiratory cell and molecular biology, 45(3), pp.582–591 (2011)
- Middeldorp S., Coppens M., van Haaps T.F., Foppen M., Vlaar A.P., Muller M.C.A., Bouman C.C.S., Beenen L.F.M., Kootte R.S., Heijmans J., Smits L.P., Bonta P.I., van Es N.: Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 18, 1995–2002 (2020)
- Fraser E.: Long term respiratory complications of covid-19. BMJ, 370, m3001 (2020)
- British Thoracic Society.: Guidance on respiratory follow up of patients with a clinico-radiological diagnosis of covid-19 pneumonia. 2020.
www.brit-thoracic.org.uk - Guan W.J, He J.X. et al.: China Medical Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 55, 2000547 (2020)
- Pranata R., Soeroto A.Y., Huang I., Lim M.A., Santoso P., Permana H., Lukito A.A.: Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19. Int J Tuberc Lung Dis. 24, 838–843 (2020)
- Lofus P.A., and Wise S.K.: Epidemiology of asthma. Curr Opin Otolaryngol Head Neck Surg. 24, 245–249 (2016)
- McCracken J.L., Veeranki S.P., Ameredes B.T., Calhoun W.J.: Diagnosis and management of asthma in adults: A review. JAMA, 318, 279–290 (2017)
- Gaga M., and Zervas E.: Oral steroids in asthma: a double-edged sword. Eur Respir J. 54, 1902034 (2019)
- Nicholson K.G., Kent J., Ireland D.C.: Respiratory viruses and exacerbations of asthma in adults. BMJ, 307, 982–986 (1993)
- Abrams E.M., Jong G.W., Yang C.L.: Asthma and COVID-19. CMAJ, 192, E551 (2020)
- Ruan Q., Yang K., Wang W., Jiang L., Song J.: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46, 846–848 (2020)
- Shabrawishi M., Alwafi H. et al. Clinical, radiological, and therapeutic characteristics of patients with COVID-19 in Saudi Arabia. PLoS One, 15, e0237130 (2020)
- Rezende L.F.M., Thome B., Schveitzer M.C., Souza-, Junior P.B de, Szwarcwald C.L.: Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil. Revista De Saúde Pública, 54, 50 (2020).
- Borobia A.M., Arribas J.R. et al.: On behalf of the Covid Hulp Working Group. A cohort of patients with COVID-19 in a major teaching hospital in Europe. J Clin Med. 9, 1733 (2020)
- Izquierdo J.L., Almonacid C., Gonzalez Y., Rio-Bermudez C.D., Ancochea J., Cardenas R., Lumbreras S., Soriano J.B.: The impact of covid-19 on patients with asthma. Eur Respir J. 57, 2003142 (2020)
- Chhiba K.D., Patel G.B., Vu T.H.T., Chen M.M., Guo A., Kudlaty E., Mai Q., Yeh C., Muhammad L.N., Harris K.E., Bochner B.S., Grammer L.C., Greenberger P.A., Kalhan R., Kuang F.L., Saltoun C.A., Schleimer R.P., Stevens W.W., Peters A.T.: Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. J Allergy Clin Immunol. 146, 307–314 (2020)
- Zhang J.J., Dong X., Cao Y.Y., Yuan Y.D., Yang Y.B., Yan Y.Q., Akdis C.A., Gao Y.D.: Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy, 75, 1730–1741 (2020)
- Chen N., Zhang L. et al.: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395, 507–513 (2020).
- Grandbastien M., de Blay F. et al.: SARS-CoV-2 pneumonia in hospitalized asthmatic patients did not induce severe exacerbation. J Allergy Clin Immunol Pract. 8, 2600–2607 (2020)
- Docherty A.B., Semple M.G. et al.: Features of 16,749 hospitalized UK patients with COVID-19 using the ISARIC WHO clinical characterization protocol. BMJ, 2020 (2020).
- CDC COVID-19 Response Team.: Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 – United States, February 12 – March 28, 2020. MMWR Morb Mortal Wkly Rep. 69, 382–386 (2020)
- Carli G., Cecchi L., Stebbing J., Parronchi P., Farsi A.: Is asthma protective against COVID-19? Allergy, 2020 (2020).
- Ferastraoaru D., Hudes G., Jerschow E., Jariwala S., Karagic M., Vos G de., Rosenstreich D., Ramesh M.: Eosinophilia in asthma patients is protective against severe COVID-19 illness. J Allergy Clin Immunol Pract. 9, 1152–1162 (2021)
- Hughes-Visentin A., Paul A.B.M.: Asthma and COVID-19: What do we know now. Clin Med Insights Circ Respir Pulm Med. 14, 1179548420966242 (2020).
- Halpin D.M.G., Singh D., Hadfield R.M.: Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J. 55(5), 2001009 (2020)
- Farne H., Singanayagam A.: Why asthma might surprisingly protect against poor outcomes in COVID-19. Eur Respir J. 56(6), 2003045 (2020).
- Sajuthi S.P., Seibold M.A. et al.: Type 2 and interferon inflammation strongly regulates SARS-CoV-2 related gene expression in the airway epithelium. Nat Comm. 11, 5139 (2020)
- Alsofayan Y.M., Althunayyan S.M., Khan A.A., Hakawi A.M., Assiri A.M.: Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study. J Infect Public Health, 13, 920–925 (2020).
- Shaker M.S., Greenhawt M. et al.: COVID-19: Pandemic contingency planning for the allergy and immunology clinic. J Allergy Clin Immunol Pract. 8(5), 1477–1488 (2020)
- Levin M., Wong G.W.K. et al.: Acute asthma management during SARS-CoV-2 pandemic 2020. World Allergy Org J. 13(5), 100125 (2020)
- Corman V.M., Muth D., Niemeyer D., Drosten C.: Hosts and sources of endemic human coronaviruses. Adv Virus Res. 100, 163–188 (2018)
- Guan Y., Poon L.L.M. et al.: Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China. In: Learning from SARS: Preparing for the next disease outbreak: Workshop summary. Institute of Medicine (US) Forum on Microbial Threats; Knobler S, Mahmoud A, Lemon S, et al., editors. Washington (DC): National Academies Press (US); 2004.